Sunscreen with a combination of carnauba wax and hydrogenated rapeseed oil
Patent Information
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-04-30
- Publication Date
- 2026-04-02
AI Technical Summary
Existing sunscreens rely on polymeric film-formers like polyacrylates and polyvinylpyrrolidones to enhance water resistance, which are increasingly viewed critically due to environmental concerns, necessitating the development of alternatives that maintain water resistance without these compounds.
A cosmetic sunscreen formulation incorporating carnauba wax, hydrogenated rapeseed oil, and optional cetyl palmitate and/or C18-38 alkyl hydroxystearate, combined with specific UV filters, to enhance water resistance without polymeric film-formers.
The formulation maintains high SPF and water resistance upon exposure to water, addressing environmental concerns while providing effective UV protection.
Description
[0001] The present invention relates to a cosmetic preparation containing a) one or more UV filters, b) carnauba wax (INCI Copernicia Cerifera Cera) and c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) and processes and uses involving carnauba wax (INCI Copernicia Cerifera Cera) and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in cosmetic sunscreens.
[0002] The trend away from a pale complexion and towards a "healthy, sporty tan" has been unbroken for years. To achieve this, people expose their skin to sunlight, as this stimulates pigment production in the form of melanin. However, the ultraviolet radiation in sunlight also has a damaging effect on the skin. In addition to acute damage (sunburn), long-term damage such as an increased risk of developing skin cancer occurs with excessive exposure to UVB light (wavelength: 280-320 nm). Furthermore, excessive exposure to UVB and UVA radiation (wavelength: 320-400 nm) leads to a weakening of the elastic and collagen fibers of the connective tissue. This results in numerous phototoxic and photoallergic reactions and premature skin aging.
[0003] To protect the skin, a range of sunscreen filters have been developed for use in cosmetic preparations. These UVA and UVB filters are listed in positive lists in most industrialized countries, such as Annex 7 of the Cosmetics Regulation.
[0004] However, the large number of commercially available sunscreens should not obscure the fact that these state-of-the-art preparations have a number of disadvantages.
[0005] A widespread use of cosmetic sunscreens is in the context of water sports. Sunscreens are frequently used in connection with beach vacations, visits to swimming pools, bathing, surfing, diving, paddling, or other activities where human skin comes into contact with water.
[0006] For all these activities, comprehensive UV protection depends on the sunscreen having a certain water resistance and not being immediately washed off the skin upon contact with water.
[0007] To increase the water resistance of cosmetic sunscreens, film-forming agents are typically added to these preparations. These film-forming agents are usually polymeric compounds based on polyacrylates or polyvinylpyrrolidones, which form a protective film on the skin to prevent or delay the washing off of the UV filters.
[0008] The use of such film-forming agents is increasingly viewed critically by the general public. In public discourse, concerns are frequently raised that polymeric film-forming agents, similar to so-called "microplastics," can pose a burden on the environment. Whether such concerns are justified and scientifically sound can remain undecided within the scope of this disclosure. The fact remains, however, that cosmetic manufacturers and consumers are increasingly interested in developing alternative technologies to ensure the water resistance of sunscreens.
[0009] The object of the present invention was therefore to develop a sunscreen that is as water-resistant as possible and largely avoids the use of polymeric film formers (especially those based on polyacrylates and polyvinylpyrrolidones).
[0010] The problem is surprisingly solved by a cosmetic sunscreen containing a) one or more UV filters, b) carnauba wax (INCI Copernicia Cerifera Cera), c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), characterized in that the preparation or sunscreen additionally contains cetyl palmitate (INCI: Cetyl Palmitate) and / or C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 alkyl hydroxystearoyl stearate) contains, as well as containing a cosmetic sunscreen a) one or more UV filters, b) carnauba wax (INCI Copernicia Cerifera Cera), c) hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil), characterized in that the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl-1,3-propanediol.
[0011] The sun protection factor (SPF) determined upon contact with water is calculated using the following method: In Vivo Determination of Sun Protection International Standard ISO 24444; 2010, Sun Product Very Water Resistance -Spa Pool, COLIPA 2005.
[0012] According to the invention, the use of a combination of carnauba wax (INCI Copernicia Cerifera Cera) and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) to increase the water resistance of cosmetic sunscreens is also included.
[0013] The terms "according to the invention", "advantageous according to the invention", etc., always refer within the scope of the present disclosure to the cosmetic preparation (sunscreen) according to the invention and the uses according to the invention, unless otherwise described in individual cases.
[0014] Although the prior art includes DE102018203498 A1, DE102017202838 A1 and the entry in the GNPD database Mintel "Anti-Pollution Lip Protector SPF 20" with registration number 5906615, these publications could not point the way to the present invention.
[0015] According to the invention, all substances listed as UV filters in Annex VI of Regulation (EU) No 866 / 2014 and Regulation No 1223 / 2009 of the EU Commission shall be considered UV filters.
[0016] According to the invention, it is preferred if the sunscreen is free of polyacrylates, carbomers and polyvinylpyrrolidones.
[0017] Advantageous embodiments according to the invention are characterized in that the sunscreen additionally contains cetyl palmitate (INCI: Cetyl Palmitate) and / or C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate).
[0018] According to the invention, it is particularly preferred if the preparation or sunscreen contains cetyl palmitate (INCI: Cetyl Palmitate) and C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate).
[0019] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more UV filters selected from the group of
[0020] Compounds 4-(tert-butyl)-4'-methoxydibenzoylmethane (INCI butyl methoxydibenzoyl-methane), (2-[-4-(diethylamino)-2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: diethyl-amino hydroxybenzoyl hexyl benzoate) and 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine).
[0021] The preparation contains 4-(tert-Butyl)-4'-methoxydibenzoylmethane (INCI Butyl Methoxydibenzoylmethane), the advantageous amount according to the invention is 1 to 5% by weight, based on the total weight of the preparation.
[0022] If the preparation contains (2-[-4-(Diethylamino)-2-hydroxybenzoyl] benzoic acid hexyl ester (INCI: Diethylamino Hydroxybenzoyl Hexyl Benzoate), the advantageous concentration according to the invention is 1 to 9% by weight, based on the total weight of the preparation.
[0023] If the preparation contains 2,4-bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine), the advantageous concentration according to the invention is 0.5 to 4.5% by weight based on the total weight of the preparation.
[0024] Furthermore, advantageous embodiments according to the invention are characterized in that they comprise one or more UV filters selected from the group consisting of the following compounds: 2-phenylbenzimidazole-5-sulfonic acid salts; phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid salts; 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid isoamyl ester; 2-Hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-Dihydroxy-4-methoxybenzophenone; homomenthyl salicylate;2-Ethylhexyl-2-hydroxybenzoat; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysilo-xan / Dimethylsiloxan - Copolymer; Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-ben-zoësäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone); 2,4,6-Tribiphenyl-4-yl-1,3,5-triazin; Merocyanine; Piperazinderivate;Titandioxid; Zinkoxid, enthalten.;
[0025] The use of phenylbenzimidazole-5-sulfonic acid salts, ethylhexyl salicylate, homomenthyl salicylate, 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate, dioctyl butylamidotriazone (INCI: Diethylhexyl Butamidotriazone), 4,4',4"-(1,3,5-triazine-2,4,6-triyltriimino)-tris-benzoic acid tris(2-ethylhexyl ester) (INCI: Ethylhexyl Triazone), and titanium dioxide is particularly preferred according to the invention. The UV filters phenylbenzimidazole-5-sulfonic acid salts, ethylhexyl salicylate, and dioctyl butylamidotriazone (INCI: Diethylhexyl Butamidotriazone) are particularly preferred according to the invention. 4,4',4"-(1,3,5-triazine-2,4,6-triyltriimino)-tris-benzoic acid tris(2-ethylhexyl ester) (INCI: Ethylhexyl Triazone).
[0026] The preferred concentrations according to the invention for phenylbenzimidazole-5-sulfonic acid salts are from 0.5 to 4 wt.%, based on the total weight of the preparation, and the preferred concentration for ethylhexyl salicylate is from 0.5 to 5 wt.%, based on the total weight.
[0027] It is advantageous in the sense of the present invention if the preparation contains one or more UV filters a) in a total concentration of 1 to 30 wt%, based on the total weight of the preparation.
[0028] The preparation according to the invention can advantageously be in different product forms.
[0029] In a first advantageous embodiment, the preparation is in the form of a spray.
[0030] In this case, the advantageous embodiment according to the invention is characterized in that the spray formulation
[0031] Contains carnauba wax (INCI Copernicia Cerifera Cera) in a concentration of 0.1 to 4% by weight and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.1 to 4% by weight, each based on the total weight of the preparation.
[0032] If the preparation according to the invention is in the form of a spray, it preferably has a viscosity of 50 to 3000 mPas, measured with (Rheomat R123 from proRheo + Rotor 1 (300-10,000 mPas) Rotor 3 (30-1000 mPas) 25°C ±0.2°C, rotational speed (n=62.5 min -1< )(measured in a 150 mL wide-mouth screw-top jar)
[0033] In a second advantageous embodiment, the preparation can be in the form of an emulsion. In such a case, it is advantageous according to the invention if the emulsion contains carnauba wax (INCI: Copernicia Cerifera Cera) in a concentration of 0.1 to 4% by weight and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.1 to 4% by weight, each based on the total weight of the preparation.
[0034] The advantageous emulsion type according to the invention is the O / W emulsion and W / O. If the preparation according to the invention is in the form of an O / W emulsion, it is advantageously characterized according to the invention in that the preparation contains one or more O / W emulsifiers selected from the group of compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycosederate, sodium cetearyl sulfate, potassium cetyl phosphate, polyglyceryl-10 stearate, sodium stearyl glutamate.
[0035] If the preparation according to the invention is in the form of a W / O emulsion, it is advantageously characterized according to the invention in that the preparation contains one or more W / O emulsifiers selected from the group of compounds Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate, Polyglyceryl-3 Polyricinoleate and / or Polyglyceryl-2 Sesquioleate.
[0036] In a third advantageous embodiment, the preparation can be in the form of an alcoholic preparation. The preferred embodiment according to the invention is the alcoholic spray.
[0037] According to the invention, the alcoholic preparation advantageously contains carnauba wax (INCI Copernicia Cerifera Cera) in a concentration of 0.1 to 3 wt.% and hydrogenated rapeseed oil (INCI: hydrogenated rapeseed oil) in a concentration of 0.1 to 3 wt.%, each based on the total weight of the preparation.
[0038] In the context of the present invention, an "ethanolic preparation" is understood to be a sunscreen containing at least 10% ethanol by weight, based on the total weight of the preparation. According to the invention, such an ethanolic sunscreen preferably contains 20% to 75% ethanol by weight, and particularly preferably 25% to 70% ethanol by weight, in each case based on the total weight of the preparation.
[0039] Preferred embodiments of the present invention are characterized in that the preparation contains cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1 to 4% by weight, based on the total weight of the preparation.
[0040] Furthermore, according to the invention, it is preferred if the preparation contains C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate) in a concentration of 0.1 to 4% by weight, based on the total weight of the preparation.
[0041] According to the invention, it is advantageous if the preparation contains xanthan gum (INCI: Xanthan Gum).
[0042] In such a case, the embodiments preferred according to the invention are characterized in that the preparation contains xanthan gum (INCI: Xanthan Gum) in a concentration of 0.05 to 2% by weight, based on the total weight of the preparation.
[0043] Advantageous embodiments according to the present invention are characterized in that the preparation contains phenoxyethanol, ethylhexylglycerin and / or 4-hydroxyacetophenone.
[0044] Furthermore, according to the invention, it is advantageous if the preparation contains one or more alkanediols from the group of compounds 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, 2-methyl-1,3-propanediol.
[0045] Furthermore, according to the invention, it is advantageous if the preparation is free of 3-(4-methylbenzylidene)-camphor, 2-hydroxy-4-methoxybenzophenone (INCI: oxybenzone), 4-methoxycinnamic acid 2-ethylhexyl ester (INCI: octyl methoxycinnamate), octocrylene, parabens (especially propyl and butyl paraben), methylisothiazolinone, chloromethyl-isothiazolinone and DMDM hydantoin, polyethylene glycol ethers or polyethylene glycol esters.
[0046] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more compounds selected from the group consisting of alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, flavonoids, creatine, creatinine, taurine, β-alanine, panthenol, magnolol, honokiol, tocopheryl acetate, dihydroxyacetone; thiamidol; 8-hexadecene-1,16-dicarboxylic acid, glyceryl glycose, (2-hydroxyethyl)urea, vitamin E or its derivatives, hyaluronic acid and / or its salts and / or licochalcone A.
[0047] The preparation according to the invention can advantageously contain humectants. Humectants (moisturizers) are substances or mixtures of substances which give cosmetic preparations the property of reducing the moisture loss from the stratum corneum (also called transepidermal water loss (TEWL)) and / or positively influencing the hydration of the stratum corneum after application or distribution on the skin surface.
[0048] Advantageous humectants (moisturizers) within the meaning of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharide gum-1, glycine soja, ethylhexyloxyglycerin, pyrrolidone carboxylic acid, and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gellable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan, and / or a fucose-rich polysaccharide, which is listed in the Chemical Abstracts under registration number 178463-23-5 and is available, for example, under the name Fucogel®<1000 from SOLABIA SA. Moisturizers can also advantageously be used as anti-wrinkle agents to protect against skin changes such as those caused by, for example, aging, wrinkles, or other skin irritations. B. can be used in cases of skin aging.
[0049] The cosmetic preparations according to the invention may further advantageously, although not necessarily, contain fillers which, for example, further improve the sensory and cosmetic properties of the formulations and, for instance, create or enhance a velvety or silky skin feel. Advantageous fillers within the meaning of the present invention are starch and starch derivatives (such as tapioca starch, distarch phosphate, aluminum or sodium starch octenyl succinate, and the like), pigments that have neither a primarily UV-filtering nor a coloring effect (such as boron nitride, etc.), and / or Aerosile® (CAS No. 7631-86-9), and / or talc, and / or polyethylene, nylon.
[0050] According to the invention, it is preferred if the preparation according to the invention contains tapioca starch and / or distarch phosphate.
[0051] Advantageous embodiments of the present invention are characterized in that the preparation contains one or more oils selected from the group consisting of the following compounds: Butylene Glycol Dicaprylate / Dicaprate, Phenethyl Benzoate, C12-15 Alkyl Benzoate, Dibutyl Adipate, Diisopropyl Sebacate, Dicaprylyl Carbonate, Di-C12-13 Alkyl Tartrate, Butyloctyl Salicylate, Diethylhexyl Syringylidene Malonate, Hydrated Castor Oil Dimerate, Triheptanoin, C12-13 Alkyl Lactate, C16-17 Alkyl Benzoate, Propylheptyl Caprylate, Caprylic / Capric Triglyceride, Diethylhexyl 2,6-Naphthalate, Octyldodecanol, Caprylic / Capric Triglyceride, Ethylhexyl Cocoate.
[0052] According to the invention, it is preferred if the preparation contains dibutyl adipate, dicaprylyl carbonate, butylene glycol dicaprylate / dicaprate and / or C12-C15 alkyl benzoate.
[0053] The aqueous phase of the preparations according to the invention can advantageously contain conventional cosmetic excipients, such as alcohols, in particular those with a low carbon number, preferably ethanol and / or isopropanol or polyols with a low carbon number and their ethers, preferably propylene glycol, glycerin, electrolytes, self-tanning agents, and in particular one or more thickening agents, which or which can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or their derivatives, e.g. hyaluronic acid, hydroxypropyl methylcellulose.
[0054] It is further advantageous in the sense of the present invention if the preparation according to the invention comprises one or more perfume substances selected from the group consisting of the following compounds: limonene, citral, linalool, alpha-isomethyl ionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetralin, adipic acid diesters, alpha-amylcinnamaldehyde, alpha-methyl ionone, amyl C, butylphenyl methylpropional cinnamal, amyl salicylate, amylcinnamyl alcohol, anise alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenyl methylpropional, cardamom oil, cedrol, cinnamal. Cinnamyl alcohol, citronellyl methyl crotonate, lemon oil, coumarin, diethyl succinate, ethyl linalool, eugenol, Evernia furfuracea extract, Evernia prunastri extract, farnesol, guaiac wood oil, hexyl cinnamal, hexyl salicylate, hydroxycitronellal, lavender oil, lemon oil, linalyl acetate, mandarin oilContains menthyl PCA, methylheptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, tonka bean oil, triethyl citrate and / or vanillin.
[0055] Furthermore, the preparations according to the invention can contain the ingredients commonly used in cosmetic sunscreens in the usual concentrations. Vergleichsversuch
[0056] The effect according to the invention was demonstrated by the following comparative experiment. The following formulations were prepared. inci A B C Sodium Stearoyl Glutamate + Sodium Chloride 0,4 0,4 0,4 Glyceryl Stearate 1 1 1 Dibutyl Adipate 3 3 3 Isopropyl Palmitate 6 6 6 Butylene Glycol Dicaprylate / Dicaprate 2 2 2 Cetyl Palmitate 0,4 0,4 0,4 Hydrogenated Rapeseed Oil 0,5 0,5 0,5 C18-38 Alkyl Hydroxystearoyl Stearate 0,5 0 0,5 Copernicia Cerifera Cera 0 0,5 0,5 Konservierung (Alcohol Denat. + Aqua, Phenoxyethanol) 7,4 7,4 7,4 Hydroxyacetophenone 0,2 0,2 0 Xanthan Gum 0,2 0,2 0,2 Microcrystalline Cellulose + Cellulose Gum 1 1 1 Tocopheryl Acetate 0,1 0,1 0,1 UV Filter (Butyl Methoxydibenzoylmethane, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Ethylhexyl Salicylate, Ethylhexyl Triazone, Phenylbenzimidazole Sulfonic Acid) 11,3 11,3 11,3 Glycerin 5 5 5 Caprylyl Glvcol 0 0 0,15 Parfum 0,5 0,5 0,5 Aqua + Trisodium EDTA 1 1 1 Aqua + Sodium Hydroxide 0,165 0,165 0,165 Aqua ad 100 ad 100 ad 100 SPF 31,5 40,5 36 SPW [%] 48 54 63 Beispiele
[0057] The following examples are intended to illustrate the present invention without limiting it. Unless otherwise stated, all quantities, proportions, and percentages are based on the weight and total quantity or total weight of the preparations. inci A B C D E F Sodium Stearoyl Glutamate + Sodium Chloride 0,2 0,2 Polyglyceryl-10 Stearate 0,5 Glyceryl Stearate Citrate 0,5 Polyglyceryl-3 Methylglucose Distearate 0,2 0,2 0,2 Glyceryl Stearate SE 0,2 Sodium Cetearyl Sulfate 0,4 Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate 1 Dibutyl Adipate 1 3 1 2 5 Isopropyl Palmitate 3 2 3 10 Butylene Glvcol Dicaprylate / Dicaprate 4 2 3 2 5 Octyldodecanol 16,825 C12-15 Alkyl Benzoate 1 3 3 2 2 9 Propylheptyl Caprylate 5 Glyceryl Stearate 0,75 0,2 0,5 Cetyl Palmitate 2 1 1 0,5 Hydrogenated Rapeseed Oil 1 2 3 0,25 0,75 0,5 C18-38 Alkyl Hydroxystearoyl Stearate 0,25 0,15 Copernicia Cerifera Cera 0,25 1 0,5 3 1,12 0,5 Synthetic Beeswax 0,2 Hydrogenated Coco-Glycerides 0,25 Synthetic Wax 0,5 Phenylbenzimidazole Sulfonic Acid 1 0,5 1 2 Ethylhexyl Salicylate 3 1 2 3,3 2 4,5 Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 2,5 3 2 2,5 3,5 2 Ethylhexyl Triazone 2 1 2 1 Butyl Methoxydibenzoylmethane 2,5 4,75 3 2,5 3 3 Diethylamino Hydroxybenzoyl Hexyl Benzoate 1 1 2 1 3 Homosalate 0,9 Diethylhexyl Butamido Triazone 1 1 1 1 0,5 Xanthan Gum 0,1 0,15 0,3 0,25 0,4 0,05 Microcrystalline Cellulose + Cellulose Gum 1,5 1,5 0,75 1 0,5 Alcohol Denat. + Aqua 6 4 3 5 7 30 Hydroxyacetophenone 0,1 0,2 0,35 0,1 Caprylyl Glycol 0,1 Phenoxyethanol 0,2 0,2 0,5 Aqua + Trisodium EDTA 0,5 0,25 0,3 0,125 Ethylhexylglycerin 0,2 Aqua + Sodium Hydroxide 0,33 0,165 0,33 0,66 Tocopheryl Acetate 0,5 1 0,75 0,5 2 Glycerin 3 5 7 3 4 1 Parfum 0,4 0,2 0,5 0,3 0,5 0,6 Aqua ad 100 ad 100 ad 100 ad 100 ad 100
Claims
1. Cosmetic sunscreen comprising a) one or more UV filters, b) carnauba wax (INCI: Copernicia Cerifera Cera), c) hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil), characterized in that the preparation or the sunscreen additionally comprises cetyl palmitate (INCI: Cetyl Palmitate) and / or C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate).
2. Cosmetic sunscreen comprising a) one or more UV filters, b) carnauba wax (INCI: Copernicia Cerifera Cera), c) hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil), characterized in that the preparation comprises one or more alkanediols from the following group of compounds: pentane-1,2-diol, hexane-1,2-diol, octane-1,2-diol, decane-1,2-diol, 2-methylpropane-1,3-diol.
3. Use of a combination of sunscreen camauba wax (INCI: Copernicia Cerifera Cera) and hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil) to increase the water resistance of cosmetic sunscreens.
4. Preparation or use according to any of the preceding claims, characterized in that the preparation or the sunscreen is free of polyacrylates, carbomers and polyvinylpyrrolidones.
5. Use according to any of the preceding claims, characterized in that the preparation or the sunscreen additionally comprises cetyl palmitate (INCI: Cetyl Palmitate) and / or C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate).
6. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises one or more UV filters selected from the following group of compounds: 4-(tert-butyl)-4'-methoxydibenzoylmethane (INCI: Butyl Methoxydibenzoylmethane), hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate (INCI: Diethylamino Hydroxybenzoyl Hexyl Benzoate) and 2,4-bis{[4-(2-ethylhexyloxy)-2-hydroxy]phenyl}-6-(4-methoxyphenyl)-1,3,5-triazine (INCI: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine).
7. Cosmetic preparation or use according to any of the preceding claims, characterized in that it comprises one or more UV filters selected from the following group of compounds: 2-phenylbenzimidazole-5-sulfonic acid salts; phenylene-1,4-bis(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bomylidenemethyl)benzene and salts thereof; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]phenol; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid salts; 2-ethylhexyl 2-cyano-3,3-diphenylacrylate; amyl 4-(dimethylamino)benzoate; di(2-ethylhexyl) 4-methoxybenzalmalonate; isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; hexyl 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoate; homomenthyl salicylate; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3-(4-(2,2-bisethoxycarbonylvinyl)phenoxy)propenyl)methoxysiloxane / dimethylsiloxane copolymer; dioctyl butylamido triazone (INCI: Diethylhexyl Butamido Triazone); 2,4-bis[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2-ethylhexyl)imino-1,3,5-triazine (with CAS No. 288254-16-0); tris(2-ethylhexyl) 4,4',4"-(1,3,5-triazine-2,4,6-triyltriimino)trisbenzoate (also: 2,4,6-tris[anilino-(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone); 2,4,6-tris(biphenyl-4-yl)-1,3,5-triazine; merocyanines; piperazine derivatives; titanium dioxide; zinc oxide.
8. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises one or more UV filters a) in a total concentration of 1% to 30% by weight, based on the total weight of the preparation.
9. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation is in the form of a spray.
10. Cosmetic preparation or use according to Claim 9, characterized in that comprises carnauba wax (INCI: Copernicia Cerifera Cera) in a concentration of 0.1% to 4.0% by weight and hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil) in a concentration of 0.1% to 4.0% by weight, in each case based on the total weight of the preparation.
11. Cosmetic preparation or use according to any of the preceding Claims 1 to 8, characterized in that the preparation is in the form of an emulsion or an alcoholic preparation.
12. Cosmetic preparation or use according to Claim 11, wherein the preparation is in the form of an emulsion, characterized in that comprises carnauba wax (INCI: Copernicia Cerifera Cera) in a concentration of 0.1% to 4.0% by weight and hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil) in a concentration of 0.1% to 4.0% by weight, in each case based on the total weight of the preparation.
13. Cosmetic preparation or use according to Claim 11, wherein the preparation is in the form of an alcoholic preparation, characterized in that comprises carnauba wax (INCI: Copernicia Cerifera Cera) in a concentration of 0.1% to 3.0% by weight and hydrogenated rapeseed oil (INCI: Hydrogenated Rapeseed Oil) in a concentration of 0.1% to 3.0% by weight, in each case based on the total weight of the preparation.
14. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises cetyl palmitate (INCI: Cetyl Palmitate) in a concentration of 0.1% to 4.0% by weight, based on the total weight of the preparation.
15. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises C18-38 alkyl hydroxystearoyl stearate (INCI: C18-38 Alkyl Hydroxystearoyl Stearate) in a concentration of 0.1% to 4.0% by weight, based on the total weight of the preparation.
16. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises xanthan gum (INCI: Xanthan Gum).
17. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises xanthan gum (INCI: Xanthan Gum) in a concentration of 0.05% to 2.0% by weight, based on the total weight of the preparation.
18. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation comprises phenoxyethanol, ethylhexylglycerin and / or 4-hydroxyacetophenone.
19. Use according to any of the preceding claims, characterized in that the preparation comprises one or more alkanediols from the following group of compounds: pentane-1,2-diol, hexane-1,2-diol, octane-1,2-diol, decane-1,2-diol, 2-methylpropane-1,3-diol.
20. Cosmetic preparation or use according to any of the preceding claims, characterized in that the preparation is free of 3-(4-methylbenzylidene)camphor, 2-hydroxy-4-methoxybenzophenone (INCI: Oxybenzone), 2-ethylhexyl 4-methoxycinnamate (INCI: Octyl Methoxycinnamate), octocrylene, parabens, methylisothiazolinone, chloromethylisothiazolinone and DMDM hydantoin, polyethylene glycol ethers or polyethylene glycol esters.